Innovative Therapies Call for an Integrated Drug Safety and Compliance Model

In this article, Herbert Lee, PharmD, Senior Vice President, Medical Communications and Pharmacovigilance, makes the case for an integrated approach to ensuring the safe and effective use of medications by patients.

From emerging therapies to innovative technologies, the healthcare industry is changing – demanding that we do business differently. Working in one of the most regulated industries, we need to understand the complexities of developing products/services that meet patient need and help improve the health and safety of the public. Safety and compliance are important areas of focus in every industry I can think of and especially in life sciences. As the global environment evolves, so must our models for pharmacovigilance and medical communications. The question now becomes, how do we deliver innovative healthcare safely and effectively, and provide value to patients, providers, payers and manufacturers?

To read the full article, click to download

Download
“Innovative Therapies Call for an Integrated Drug Safety and Compliance Model”
Downloaded 27 times – 209 KB
Author
Herbert Lee, PharmD, MBA
Senior Vice President, Medical Communications & Pharmacovigilance

Herbert Lee, PharmD, MBA is leading the Pharmacovigilance, Medical Communications and Quality teams for EVERSANA.   He has over 30 years of experience managing medical information and communication services. He drives the vision to create an efficient, effective and easy to use health experience by providing contact center services on behalf of our clients, using an […]